In response to the RFA RR-O1-007 entitled """"""""NCMHD Endowment Program for Increasing Research and Training Capacity in Section 736 Health Professions Schools"""""""" the Charles R. Drew University of Medicine and Science (DREW) seeks to establish an endowment that will create and sustain the DREW """"""""Research & Educational Advancement Center for Health Disparities (REACH)."""""""" REACH will be a new component within the DREW Learning Resource Center (LRC). Specifically, REACH will enhance institutional infrastructure and programming for faculty development and the student Medical Thesis program, with an emphasis on health disparities research. The addition of a Medical Thesis program with an emphasis on health disparities at DREW will further bolster the research and academic foundation of our medical students. Over the last 5 years, DREW has graduated 97/110 (88%) underrepresented medical students and is presently the only medical school with a required primary care research project. REACH will combine a culturally sensitive research methodology curriculum with an active research experience in areas such as communitybased research, health outcome research, and research ethics in multicultural communities. REACH will provide these junior faculty and medical students with the tools to address health disparities as clinicians, researchers, health policy makers and/or community educators, and encourage the creation of novel and innovative ways to address these disparities. Thus, REACH will address the National Institutes of Health (NIH) Health Disparities Strategic Plan of training a pool of underrepresented junior faculty and medical students with a heightened sense of awareness of the critical areas where health care disparities exist. The proposed endowment will be managed through DREW's collaboration with University of California, Los Angeles (UCLA) providing an established foundation of effective and sophisticated portfolio endowment management consistent with the highest level of standards in the nation. The endowment's portfolio is expected to generate a total annualized rate of return, net of fees, 5% greater than the rate of inflation as measured by the national consumer price index over a rolling 5-year period. The Foundation's spending policy governs the rate at which funds are released to fundholders for their current spending and is reviewed annually by the Finance Committe. To achieve its investment objectives, the Endowment portfolio will be allocated among a number of asset classes that may include domestic equity, domestic fixed income, international equity, venture capital and cash. The purpose of allocating the investment portfolio's asset classes is to ensure the proper level of diversification within the Endowment. This will ensure the fiscal solvency necessary for creating a self- sustaining program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research and Institutional Resources Health Disparities Endowment Grants -Capacity Building (S21)
Project #
1S21MD000103-01
Application #
6494333
Study Section
Special Emphasis Panel (ZRR1-RI-5 (02))
Program Officer
Stinson, Nathaniel
Project Start
2001-09-30
Project End
2005-09-29
Budget Start
2001-09-30
Budget End
2002-09-29
Support Year
1
Fiscal Year
2001
Total Cost
$4,000,000
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Elsaid, Ahmed F; Shaheen, Magda; Ghoneum, Mamdooh (2018) Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial. Exp Ther Med 15:2313-2320
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Singh, Rajan; Pervin, Shehla; Lee, Se-Jin et al. (2018) Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases. Diabetes Metab Syndr Obes 11:65-84
Jenders, Robert A; Adlassnig, Klaus-Peter; Fehre, Karsten et al. (2018) Evolution of the Arden Syntax: Key Technical Issues from the Standards Development Organization Perspective. Artif Intell Med 92:10-14
Hanuscin, Chris; Zahmatkesh, Golara; Shirazi, Anaheed et al. (2018) Socio-Demographic and Mental Health Profile of Admitted Cases of Self-Inflicted Harm in the US Population. Int J Environ Res Public Health 15:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Kermah, Dulcie; Shaheen, Magda; Pan, Deyu et al. (2017) Association between secondhand smoke and obesity and glucose abnormalities: data from the National Health and Nutrition Examination Survey (NHANES 1999-2010). BMJ Open Diabetes Res Care 5:e000324
Yen, Eric Y; Shaheen, Magda; Woo, Jennifer M P et al. (2017) 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study. Ann Intern Med 167:777-785
Pervin, Shehla; Singh, Vineeta; Tucker, Alexandria et al. (2017) Modulation of transforming growth factor-?/follistatin signaling and white adipose browning: therapeutic implications for obesity related disorders. Horm Mol Biol Clin Investig 31:
Wang, Piwen; Solorzano, Walter; Diaz, Tanya et al. (2017) Arctigenin inhibits prostate tumor cell growth in vitro and in vivo. Clin Nutr Exp 13:1-11

Showing the most recent 10 out of 85 publications